Table of contents
- Antitrust
- Competition policy
- Upcoming dates
Article summary
A round-up of UK competition law developments, including (amongst other things) the CMA’s decision to impose £260m of fines on numerous pharmaceutical companies for abuse of dominance and pay-for-delay agreements in the hydrocortisone tablets market.
To continue reading this news article, as well as thousands of others like it, sign in with LexisNexis or register for a free trial